Lifeward (LFWD) Gross Margin (2015 - 2026)

Lifeward (LFWD) posted Gross Margin of 34.21% for Q1 2026, up 59.76% sequentially from 21.41% in Q4 2025, and down 794.0% YoY from 4.93% in Q1 2025.

Lifeward (LFWD) Gross Margin (2015 - 2026) Analysis & Trends

Lifeward has reported Gross Margin for 12 years, with the latest figure at 34.21% in Q1 2026.

Quarterly Gross Margin fell 794.0% year-over-year to 34.21% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.55% (up 136.0% YoY) and the FY2025 annual result came in at 38.25%, up 624.0% from the prior year.
Gross Margin improved to 34.21% in Q1 2026 per LFWD's latest filing, from 21.41% in the prior quarter.
Over five years, Gross Margin peaked at 47.52% in Q2 2022 and troughed at 19.6% in Q3 2023.
A 5-year average of 34.81% and a median of 35.49% in 2023 frame the typical range for Gross Margin.
The sharpest annual moves came in 2022 and 2024: Gross Margin plunged 3287 bps in 2022, then surged 1663 bps in 2024.
Over 5 years, Gross Margin stood at 30.89% in 2022, then increased by 15 bps to 35.49% in 2023, then plunged by 31 bps to 24.44% in 2024, then fell by 12 bps to 21.41% in 2025, then jumped by 60 bps to 34.21% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 34.21%, 21.41%, and 43.7% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	57.71%
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	68.27%
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	65.35%
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	70.71%
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	77.46%
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	63.44%
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	41.17%
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	47.38%
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	45.84%
10	Lifeward	20.55 Mn	11.10 Mn	2.71 Mn	40.90%

Download Data